This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
HK$346.54
Share price
0.00%
Change (1 day)
119.98%
Change (1 year)
Categories
Market capitalization of Albireo Pharma (ALBO)
Last known market cap: HK$7.18 Billion
On May 5, 2023 Albireo Pharma had a market cap of HK$7.18 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Albireo Pharma from 2007 to 2023
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2023 | HK$7.15 B | 104.65% |
| 2022 | HK$3.49 B | -0.26% |
| 2021 | HK$3.50 B | -36.93% |
| 2020 | HK$5.55 B | 120.12% |
| 2019 | HK$2.52 B | 9.77% |
| 2018 | HK$2.29 B | 29.18% |
| 2017 | HK$1.77 B | 105.74% |
| 2016 | HK$0.86 B | 407.91% |
| 2015 | HK$0.17 B | -29.6% |
| 2014 | HK$0.24 B | -35.05% |
| 2013 | HK$0.37 B | 44.26% |
| 2012 | HK$0.25 B | 40.81% |
| 2011 | HK$0.18 B | -51.28% |
| 2010 | HK$0.37 B | -53.16% |
| 2009 | HK$0.80 B | -9% |
| 2008 | HK$0.88 B | -75.96% |
| 2007 | HK$3.67 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | HK$7.65 B | 6.44% | 🇺🇸 USA |